Reciprocal changes in trefoil 1 and 2 expression in stomachs of mice with gastric unit hypertrophy and inflammation

Journal of Pathology - Tập 207 Số 1 - Trang 43-52 - 2005
TV Franic1, Ian R. van Driel2, Paul A. Gleeson2, AS Giraud1, Louise M. Judd1
1Department of Medicine, The University of Melbourne, Western Hospital, Melbourne, VIC 3011, Australia.
2Bio21 Molecular Science and Biotechnology Institute, 30 Flemington Road, The University of Melbourne, Parkville, VIC 3010, Australia

Tóm tắt

AbstractH+/K+‐ATPase β‐subunit‐deficient mice (129/Sv background) display numerous pathologies in the stomach. Expression of the mutation in BALB/cCrSlc mice results in the development of an aberrant ‘mucus‐rich’ cell population. ‘Mucus‐rich’ cells have been described in stomachs of mice with autoimmune gastritis, a disease mediated by CD4+ T cells. Other pathological features of autoimmune gastritis are similar to those in H+/K+ β‐deficient mice and include a mononuclear cell infiltrate in the gastric mucosa, non‐functional or absent parietal cells, depletion of zymogenic cells, hypergastrinaemia, and gastric unit hypertrophy caused by immature cell hyperplasia. The present study investigates further the aberrant gastric ‘mucus‐rich’ cell lineage and analyses the mRNA expression of mucus cell products TFF1 and TFF2. ‘Mucus‐rich’ cells stained for both acidic and neutral mucins, and with a TFF2‐specific antibody. Stomachs from both models expressed decreased TFF1 mRNA and reciprocally increased TFF2 mRNA. The involvement of gastrin in regulating trefoil mRNA expression was also investigated using gastrin‐deficient mice. In contrast to previous findings, gastrin did not positively regulate TFF1 mRNA expression, but there was possible augmentation of TFF2. Additionally, a clear role for inflammation was established involving both polymorphonuclear and mononuclear cells in these models, and a link was found between mucosal hypertrophy and increased interleukin‐11 (IL‐11) expression. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1038/nrm1203

10.1136/gut.44.5.636

10.1053/gast.1996.v110.pm8566596

10.1073/pnas.93.5.2137

10.1172/JCI0212529

10.1126/science.274.5285.259

10.1097/01.LAB.0000029205.76632.A8

10.1016/0016-5085(95)90014-4

10.1016/S0016-5085(00)70415-X

10.1083/jcb200108056

10.1136/gut.2003.031963

10.1016/j.peptides.2004.01.019

10.1146/annurev.physiol.63.1.119

10.1152/ajpgi.1998.274.3.G561

10.1172/JCI118993

10.1016/S0016-5085(03)00908-9

10.1016/S0016-5085(99)70453-1

10.1016/S0016-5085(19)32651-4

Sachs G, 1987, Physiology of the Gastrointestinal Tract, 865

10.3109/08916939309014648

10.1152/ajpgi.2001.281.6.G1502

10.1152/ajpgi.1999.277.1.G209

10.1007/BF02774829

10.1056/NEJM199711133372007

10.1152/ajpgi.00469.2003

10.1002/eji.1830260737

10.1084/jem.178.2.419

10.1016/S0014-5793(99)00940-0

10.1073/pnas.95.6.3122

10.1189/jlb.0803396

10.1074/jbc.M200468200

Fox JG, 2002, Germ‐line p53‐targeted disruption inhibits Helicobacter‐induced premalignant lesions and invasive gastric carcinoma through down‐regulation of Th1 proinflammatory responses, Cancer Res, 62, 696

10.1053/j.gastro.2003.10.066

10.1016/S0016-5085(98)70581-5

Schmidt PH, 1999, Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma, Lab Invest, 79, 639

10.1097/01.LAB.0000022225.45996.21

10.1053/gast.2002.30298

10.1053/gast.1996.v110.pm8964405

10.1038/nm763

10.1053/j.gastro.2004.05.029

10.1159/000066279

10.1016/S0016-5085(97)70199-9

10.1083/jcb.122.1.191

10.1002/path.1711690313